Financial results - AMENMINA PHARM SRL

Financial Summary - Amenmina Pharm Srl
Unique identification code: 29539667
Registration number: J2012000021091
Nace: 4773
Sales - Ron
457.261
Net Profit - Ron
1.982
Employees
4
Open Account
Company Amenmina Pharm Srl with Fiscal Code 29539667 recorded a turnover of 2024 of 457.261, with a net profit of 1.982 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Amenmina Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 181.534 196.518 220.863 229.708 243.700 269.369 282.535 315.924 347.943 457.261
Total Income - EUR 183.743 200.954 222.831 231.673 245.770 272.340 284.891 318.817 351.946 460.900
Total Expenses - EUR 177.965 202.715 225.782 222.691 230.361 253.474 266.757 306.324 340.657 446.481
Gross Profit/Loss - EUR 5.778 -1.761 -2.951 8.982 15.410 18.866 18.134 12.493 11.288 14.419
Net Profit/Loss - EUR 4.926 -1.761 -4.991 6.665 12.952 16.509 15.646 9.687 8.156 1.982
Employees 3 4 5 4 3 3 3 4 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 32.2%, from 347.943 euro in the year 2023, to 457.261 euro in 2024. The Net Profit decreased by -6.129 euro, from 8.156 euro in 2023, to 1.982 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Amenmina Pharm Srl

Rating financiar

Financial Rating -
AMENMINA PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Amenmina Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Amenmina Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Amenmina Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Amenmina Pharm Srl - CUI 29539667

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 4.234 4.072 3.710 3.414 3.060 2.841 3.256 2.963 2.590 2.515
Current Assets 46.058 56.564 51.210 51.839 79.237 93.062 117.396 122.244 127.105 158.220
Inventories 11.881 16.065 16.240 13.650 18.260 21.495 21.681 25.092 26.329 29.062
Receivables 16.683 7.158 27.810 29.627 27.772 36.071 37.823 39.903 45.699 46.162
Cash 17.494 33.341 7.159 8.562 33.205 35.496 57.892 57.249 55.078 82.996
Shareholders Funds 7.340 5.504 420 7.077 19.892 36.024 44.019 41.162 41.285 35.171
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 43.142 55.293 54.684 48.306 62.545 59.984 76.751 84.066 88.445 125.635
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 158.220 euro in 2024 which includes Inventories of 29.062 euro, Receivables of 46.162 euro and cash availability of 82.996 euro.
The company's Equity was valued at 35.171 euro, while total Liabilities amounted to 125.635 euro. Equity decreased by -5.882 euro, from 41.285 euro in 2023, to 35.171 in 2024.

Risk Reports Prices

Reviews - Amenmina Pharm Srl

Comments - Amenmina Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.